Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies
暂无分享,去创建一个
Mats O. Karlsson | Radojka M. Savic | R. Savic | M. Karlsson | D. Jonker | T. Kerbusch | Thomas Kerbusch | Daniël M. Jonker
[1] P. Marquet,et al. Population Pharmacokinetic Modeling of Oral Cyclosporin Using NONMEM: Comparison of Absorption Pharmacokinetic Models and Design of a Bayesian Estimator , 2004, Therapeutic drug monitoring.
[2] E. Niclas Jonsson,et al. PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM , 2005, Comput. Methods Programs Biomed..
[3] A. Melander,et al. Comparison of the kinetics of glyburide and its active metabolites in humans , 1995, Journal of clinical pharmacy and therapeutics.
[4] A. Melander,et al. Hypoglycemic Activity of Glyburide (Glibenclamide) Metabolites in Humans , 1994, Diabetes Care.
[5] M O Karlsson,et al. Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics. , 1997, British journal of clinical pharmacology.
[6] L. Block,et al. The Impact of Lag Time on the Estimation of Pharmacokinetic Parameters. I. One-Compartment Open Model , 1993, Pharmaceutical Research.
[7] W J Jusko,et al. Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics. , 1998, Journal of pharmaceutical sciences.
[8] Lewis B. Sheiner. Analysis of pharmacokinetic data using parametric models. III. Hypothesis tests and confidence intervals , 2005, Journal of Pharmacokinetics and Biopharmaceutics.
[9] R. Savic,et al. Pharmacokinetics of Desmopressin Administrated as an Oral Lyophilisate Dosage Form in Children With Primary Nocturnal Enuresis and Healthy Adults , 2006, Journal of clinical pharmacology.
[10] E. Niclas Jonsson,et al. Erratum to "PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM" [Comput. Methods Prog. Biomedicine 79 (2005) 241-257] , 2005, Comput. Methods Programs Biomed..
[11] J. Wade,et al. Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis , 1993, Journal of Pharmacokinetics and Biopharmaceutics.
[12] Mats O. Karlsson,et al. Assumption Testing in Population Pharmacokinetic Models: Illustrated with an Analysis of Moxonidine Data from Congestive Heart Failure Patients , 1998, Journal of Pharmacokinetics and Biopharmaceutics.
[13] G L Amidon,et al. A compartmental absorption and transit model for estimating oral drug absorption. , 1999, International journal of pharmaceutics.
[14] M. Karlsson,et al. Semiphysiological model for the time course of leukocytes after varying schedules of 5-fluorouracil in rats. , 2000, The Journal of pharmacology and experimental therapeutics.
[15] Malcolm Rowland,et al. Clinical pharmacokinetics : concepts and applications , 1989 .
[16] B Agoram,et al. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.
[17] E N Jonsson,et al. Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. , 1999, Computer methods and programs in biomedicine.